http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106317084-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_98d52dbd560ffbacc2e86e336d0e0b58
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F1-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F1-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F1-08
filingDate 2016-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f16d5a34b441639bd3e1cd13d0603f8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_971916b13ec2c100012167faf80be032
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64f24711f4952ff6b71f9defefc48360
publicationDate 2017-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-106317084-A
titleOfInvention A kind of tryptanthrin copper complex with antitumor activity and its synthesis method
abstract The present disclosure relates to a tryptanthrin copper complex with anti-tumor activity and its synthesis method, its structure is as follows, The tryptanthrin copper complex has obvious inhibitory effect on ovarian cancer cell line Skov3, shows potential medicinal value, and is expected to be used as a metal antitumor drug. It belongs to the field of medical technology.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107501305-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107501305-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107698609-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107698609-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107746418-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107337673-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107501331-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108558914-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109369687-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108558914-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107501331-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107488198-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107488198-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107746418-B
priorityDate 2016-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105153148-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105330666-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559356
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419475332
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559557
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1983
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73549
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6594
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452833283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24014
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25203914
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24602
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546721
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1150
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID27099
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6212
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415751153
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419517688
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557597

Total number of triples: 53.